Pp. 29-49 (21)
This chapter includes a comprehensive review of all drugs to treat
tuberculosis. The WHO has classified these drugs in five groups, with drugs in Group 1
being the most effective, and less toxic and drugs in Group 5 being drugs with
unproven efficacy or frequent side effects and/or toxicity. Each drug is discussed in
detail, including its mechanisms of action, suggested doses and side and adverse
effects, as well as the required clinical and laboratory monitoring for each drug.
Recently added drugs bedaquiine and delamanid are also included in this review.
Adverse effects, Antituberculosis drugs, Bedaquiline, Cycloserine,
Delamanid, Dose, Effectiveness, Ethambutol, Ethionamide, Fluroquinolones, Injectables,
Isoniazid, Laboratory, Linezolid, Monitoring, PAS, Pyrazinamide, Rifampin, Toxicity,
Clínica y Laboratorio de Tuberculosis Hospital General Tijuana, México.